Thomas D. Southgate - Concepedia

Author

Thomas D. Southgate

Cancer Research UK Manchester Institute

Also Known As

Thomas D. Southgate, Thomas Southgate

Publications

460

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute University of Manchester Cancer Research UK Cedars-Sinai Medical Center University of California, Los Angeles

About

Thomas D. Southgate is an author at Cancer Research UK Manchester Institute specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	166
2	Health Sciences	1	1	54
3	Natural Sciences	1	1	32
4	Public Health	1	1	16
5	Biochemistry	1	1	32

Thomas D. Southgate

Publications

414

Citations

H-Index

Page 1

	Year	Citations
E-Cadherin Inhibits Cell Surface Localization of the Pro-Migratory 5T4 Oncofetal Antigen in Mouse Embryonic Stem Cells Helen Spencer, Angela M. Eastham, Catherine L.R. Merry, Molecular Biology of the Cell	2007	111
Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors Thomas D. Southgate, Paul A. Kingston, María G. Castro Current Protocols in Neuroscience	2000	62
CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells Thomas D. Southgate, Owen J. McGinn, Fernanda Castro, PLoS ONE Cxcr4 Membrane ExpressionCell ProliferationCancer BiologyCellular PhysiologyTumor Biology	2010	54
Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors Thomas D. Southgate, Kurt M. Kroeger, Chunyan Liu, Current Protocols in Neuroscience Gene TherapiesDevelopmental BiologyMolecular NeuroscienceMedicineIon Channels	2008	34
The P140K mutant of humanO6-methylguanine-DNA-methyltransferase (MGMT) confers resistancein vitro andin vivo to temozolomide in combination with the novel MGMT inactivatorO6-(4-bromothenyl)guanine Lorna B. Woolford, Thomas D. Southgate, Geoffrey P. Margison, The Journal of Gene Medicine Chemoprevention StrategyMethylating Agent TemozolomideMolecular BiologyPharmacotherapyVitro Andin Vivo	2005	32
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4) Eyad Elkord, Adam Dangoor, Deborah J. Burt, Cancer Immunology Immunotherapy Immune EvasionCancer ImmunosurveillanceImmunologyTumor ImmunityImmunoediting	2009	30
Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase Thomas D. Southgate, Victoria Sheard, Michael D. Milsom, The Journal of Gene Medicine	2006	22
A Cancer Cell-Specific Inducer of Apoptosis Katie L. Green, Craig Brown, Geraldine E. Roeder, Human Gene Therapy ApoptosisCell DeathPathologyCancer BiologyHpv Type 16	2007	16
Adenoviruses Encoding HPRT Correct Biochemical Abnormalities of HPRT-Deficient Cells and Allow Their Survival in Negative Selection Medium Thomas D. Southgate, Derek Bain, Lynette D. Fairbanks, Metabolic Brain Disease	1999	16
Hypoxia‐targeted over‐expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT‐11) Torkjel Matzow, Rachel Cowen, Kaye J. Williams, The Journal of Gene Medicine	2007	13

Page 1